DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Virtanen V, Paunu K, Ahlskog JK, Varnai R, Sipeky C, Sundvall M.
PARP inhibitors in prostate cancer—The preclinical rationale and current clinical development.
Genes (Basel) 2019;
10 (08) 1-19
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.